Toro Corp. (Nasdaq: TORO) has announced the sale of two Aframax vessels for a total amount of $71.5 million, with an expected net gain of $42.9 million. 

In the after-hours trading session, following the announcement, $TORO has risen to $4.47, marking an increase of $0.47 (+11.75%).

Krystal Biotech, Inc. (Nasdaq: KRYS) has received significant news with the approval of VYJUVEK (beremagene geperpavec) by the U.S. Food and Drug Administration (FDA). This approval is for the treatment of patients aged six months and older who are suffering from dystrophic epidermolysis bullosa, a rare genetic disease that affects the skin and mucosal tissues.

Following this announcement, $KRYS experienced a substantial increase, closing at $96.06 with a gain of $8.61 (+9.85%) on Friday. However, in the after-hours trading, the stock is currently trading at $94.47, reflecting a decrease of $1.59 (-1.66%).

Lockheed Martin (NYSE: LMT) has announced its participation in a winning team that secured a contract from NASA. The contract is aimed at developing and demonstrating a human landing system as part of NASA's Artemis program under the Human Landing System program. This significant achievement underscores Lockheed Martin's continued involvement in space exploration.

The National Team, led by Blue Origin, includes Draper, Boeing (NYSE: BA), Astrobotic, and Honeybee Robotics, and will be responsible for the development and construction of the lunar lander.

$LMT is trading at $457.00, with a gain of $2.51 (+0.55%) in after-hours.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)